Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart

Cardiovascular Research

Volumn 94, Issue 3, 2012, Pages 460-468

  Mulligan, Christopher M ^a   Sparagna, Genevieve C ^b   Le, Catherine H ^a   De Mooy, Anthony B ^a   Routh, Melissa A ^a   Holmes, Michael G ^c   Hickson Bick, Diane L ^c   Zarini, Simona ^d   Murphy, Robert C ^d   Xu, Fred Y ^e   Hatch, Grant M ^e   McCune, Sylvia A ^b   Moore, Russell L ^b   Chicco, Adam J ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cardiolipin; Heart failure; Hypertension; Mitochondria; Polyunsaturated fatty acids

Indexed keywords

CARDIOLIPIN; CASPASE; INSULIN; LARD; LINOLEIC ACID; SAFFLOWER OIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; HEART FAILURE; HYPERTENSION; INSULIN BLOOD LEVEL; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PRESSURE; CARDIOLIPINS; HEART; HEART FAILURE; LINOLEIC ACID; MALE; MITOCHONDRIA; RATS; RATS, INBRED SHR; SAFFLOWER OIL;

EID: 84861389481     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs118     Document Type: Article

References (49)

1. Hu FB. Diet and cardiovascular disease prevention the need for a paradigm shift. J Am Coll Cardiol 2007;50:22-24.
2. Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA 2002;288:2569-2578. (Pubitemid 35386892)
3. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ et al. AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000;102: 2284-2299.
4. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114:82-96. (Pubitemid 44305278)
5. Rennison JH, McElfresh TA, Chen X, Anand VR, Hoit BD, Hoppel CL et al. Prolonged exposure to high dietary lipids is not associated with lipotoxicity in heart failure. J Mol Cell Cardiol 2009;46:883-890.
6. Chess DJ, Stanley WC. Role of diet and fuel overabundance in the development and progression of heart failure. Cardiovasc Res 2008;79:269-278. (Pubitemid 351951607)
7. Chicco AJ, Sparagna GC, McCune SA, Johnson CA, Murphy RC, Bolden DA et al. Linoleate-rich high-fat diet decreases mortality in hypertensive heart failure rats compared with lard and low-fat diets. Hypertension 2008;52:549-555.
8. Chicco AJ, Sparagna GC. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am J Physiol Cell Physiol 2007;292:C33-C44. (Pubitemid 46115119)
9. Schlame M, Rua D, Greenberg ML. The biosynthesis and functional role of cardiolipin. Prog Lipid Res 2000;39:257-288. (Pubitemid 30224706)
10. Schlame M, Ren M. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 2006;580:5450-5455. (Pubitemid 44465900)
11. Sparagna GC, Chicco AJ, Murphy RC, Bristow MR, Johnson CA, Rees ML et al. Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure. J Lipid Res 2007;48:1559-1570. (Pubitemid 47312017)
12. Sparagna GC, Johnson CA, McCune SA, Moore RL, Murphy RC. Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. J Lipid Res 2005;46:1196-1204. (Pubitemid 43109834)
13. Nasjletti A, Arthur C. Corcoran memorial lecture. The role of eicosanoids in angiotensin-dependent hypertension. Hypertension 1998;31:194-200.
14. Sweeney G. Cardiovascular effects of leptin. Nat Rev Cardiol 2010;7:22-29.
15. Heyen JR, Blasi ER, Nikula K, Rocha R, Daust HA, Frierdich G et al. Structural, functional, and molecular characterization of the SHHF model of heart failure. Am J Physiol Heart Circ Physiol 2002;283:H1775-H1784. (Pubitemid 35217010)
16. Tamura T, Said S, Andersen SM, McCune SA, Mochizuki S, Gerdes AM. Temporal regression of myocyte hypertrophy in hypertensive, heart failure-prone rats treated with an AT1-receptor antagonist. J Card Fail 2002;8:43-47. (Pubitemid 34163849)
17. Palmer JW, Tandler B, Hoppel CL. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem 1977;252: 8731-8739. (Pubitemid 8243644)
18. Chance B, Williams GR. Respiratory enzymes in oxidative phosphorylation. I. Kinetics of oxygen utilization. J Biol Chem 1955;217:383-393.
19. Srere P. Citrate snythase. Methods Enzymol 1969;13:3-5.
20. Saini-Chohan HK, Holmes MG, Chicco AJ, Taylor WA, Moore RL, McCune SA et al. Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure. J Lipid Res 2009;50:1600-1608.
21. Hatch GM. Cardiolipin biosynthesis in the isolated heart. Biochem J 1994;297(Pt 1): 201-208. (Pubitemid 24025624)
22. Hatch GM, McClarty G. Regulation of cardiolipin biosynthesis in H9c2 cardiac myoblasts by cytidine 5′-triphosphate. J Biol Chem 1996;271:25810-25816. (Pubitemid 26347409)
23. Murphy RC, Barkley RM, Zemski Berry K, Hankin J, Harrison K, Johnson C et al. Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal Biochem 2005; 346:1-42. (Pubitemid 41456623)
24. Willett WC. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease. J Cardiovasc Med (Hagerstown) 2007;8(Suppl 1):S42-S45. (Pubitemid 47429082)
25. Laaksonen DE, Nyyssonen K, Niskanen L, Rissanen TH, Salonen JT. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med 2005;165:193-199.
26. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009;119:902-907.
27. Lu B, Xu FY, Taylor WA, Feingold KR, Hatch GM. Cardiolipin synthase-1 mRNA expression does not correlate with endogenous cardiolipin synthase enzyme activity in vitro and in vivo in mammalian lipopolysaccharide models of inflammation. Inflammation 2011;34:247-254.
28. Schlame M. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J Lipid Res 2008;49:1607-1620.
29. Hatch GM. Cardiolipin: biosynthesis, remodeling and trafficking in the heart and mammalian cells (Review). Int J Mol Med 1998;1:33-41.
30. Li G, Chen S, Thompson MN, Greenberg ML. New insights into the regulation of cardiolipin biosynthesis in yeast: implications for Barth syndrome. Biochim Biophys Acta 2007;1771:432-441. (Pubitemid 46428608)
31. Claypool SM, Koehler CM. The complexity of cardiolipin in health and disease. Trends Biochem Sci 2012;37:32-41.
32. Yamaoka-Koseki S, Urade R, Kito M. Cardiolipins from rats fed different dietary lipids affect bovine heart cytochrome c oxidase activity. J Nutr 1991;121: 956-958.
33. Murray AJ, Cole MA, Lygate CA, Carr CA, Stuckey DJ, Little SE et al. Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. J Mol Cell Cardiol 2008;44:694-700.
34. Sharov VG, Todor AV, Silverman N, Goldstein S, Sabbah HN. Abnormal mitochondrial respiration in failed human myocardium. J Mol Cell Cardiol 2000;32: 2361-2367. (Pubitemid 32039785)
35. Choi SY, Gonzalvez F, Jenkins GM, Slomianny C, Chretien D, Arnoult D et al. Cardiolipin deficiency releases cytochrome c from the inner mitochondrial membrane and accelerates stimuli-elicited apoptosis. Cell Death Differ 2007;14: 597-606.
36. Ostrander DB, Sparagna GC, Amoscato AA, McMillin JB, DowhanW. Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J Biol Chem 2001;276:38061-38067.
37. Gonzalvez F, Schug ZT, Houtkooper RH, MacKenzie ED, Brooks DG, Wanders RJ et al. Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. J Cell Biol 2008;183:681-696.
38. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD et al. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 1999;96:8144-8149. (Pubitemid 29328422)
39. Tamura T, Said S, Lu W, Harris J, Neufeld D, Burbach JA et al. Is apoptosis present in progression to chronic hypertensive heart failure? J Card Fail 2000;6: 37-42. (Pubitemid 30161415)
40. Kanoh M, Takemura G, Misao J, Hayakawa Y, Aoyama T, Nishigaki K et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 1999;99: 2757-2764. (Pubitemid 29250021)
41. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA et al. Apoptosis in the failing human heart. N Engl J Med 1997;336:1131-1141.
42. Wencker D, Chandra M, Nguyen K, MiaoW, Garantziotis S, Factor SM et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 2003;111: 1497-1504. (Pubitemid 38063282)
43. Okere IC, Chandler MP, McElfresh TA, Rennison JH, Sharov V, Sabbah HN et al. Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin. Am J Physiol Heart Circ Physiol 2006;291: H38-H44.
44. Swan JW, Anker SD,Walton C, Godsland IF, Clark AL, Leyva F et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol 1997;30:527-532. (Pubitemid 27339335)
45. Stanley WC, Chandler MP. Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev 2002;7:115-130. (Pubitemid 34624800)
46. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004;18:1692-1700. (Pubitemid 39463708)
47. Kayama Y, Minamino T, Toko H, Sakamoto M, Shimizu I, Takahashi H et al. Cardiac 12/15 lipoxygenase-induced inflammation is involved in heart failure. J Exp Med 2009;206:1565-1574.
48. Jenkins CM, Cedars A, Gross RW. Eicosanoid signalling pathways in the heart. Cardiovasc Res 2009;82:240-249.
49. Galvao TF, Brown BH, Hecker PA, O'Connell KA, O'Shea KM, Sabbah HN et al. High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects. Cardiovasc Res 2012;93: 24-32.